Want to join the conversation?
Drugmaker $ALXN reported a rise in 1Q16 earnings on higher revenue. Net income rose to $92.17MM from $91.32MM, while EPS fell to $0.41 from $0.45, due to a rise in shares used for computing EPS. Revenue grew to $701.04MM from $600.33MM. Non-GAAP EPS slid to $1.11 from $1.28.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?